Tenax Therapeutics Inc. (TENX)
Tenax Therapeutics Statistics
Share Statistics
Tenax Therapeutics has 3.97M shares outstanding. The number of shares has increased by 102.75% in one year.
| Shares Outstanding | 3.97M |
| Shares Change (YoY) | 102.75% |
| Shares Change (QoQ) | 16.47% |
| Owned by Institutions (%) | 1.31% |
| Shares Floating | 3.47M |
| Failed to Deliver (FTD) Shares | 959 |
| FTD / Avg. Volume | 2.41% |
Short Selling Information
The latest short interest is 105.76K, so 3.1% of the outstanding shares have been sold short.
| Short Interest | 105.76K |
| Short % of Shares Out | 3.1% |
| Short % of Float | 3.55% |
| Short Ratio (days to cover) | 1.46 |
Valuation Ratios
The PE ratio is -53.71 and the forward PE ratio is -5.73. Tenax Therapeutics's PEG ratio is 0.54.
| PE Ratio | -53.71 |
| Forward PE | -5.73 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 10.28 |
| P/FCF Ratio | -63.83 |
| PEG Ratio | 0.54 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tenax Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.6, with a Debt / Equity ratio of 0.
| Current Ratio | 20.6 |
| Quick Ratio | 20.6 |
| Debt / Equity | 0 |
| Debt / EBITDA | - |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-4.4M |
| Employee Count | 4 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 51.83% in the last 52 weeks. The beta is 1.87, so Tenax Therapeutics's price volatility has been higher than the market average.
| Beta | 1.87 |
| 52-Week Price Change | 51.83% |
| 50-Day Moving Average | 6.4 |
| 200-Day Moving Average | 4.88 |
| Relative Strength Index (RSI) | 39.68 |
| Average Volume (20 Days) | 39.87K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -17.6M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 94.85M in cash and 0 in debt, giving a net cash position of 94.85M.
| Cash & Cash Equivalents | 94.85M |
| Total Debt | 0 |
| Net Cash | 94.85M |
| Retained Earnings | -314.86M |
| Total Assets | 96.69M |
| Working Capital | 91.99M |
Cash Flow
In the last 12 months, operating cash flow was -14.81M and capital expenditures 0, giving a free cash flow of -14.81M.
| Operating Cash Flow | -14.81M |
| Capital Expenditures | 0 |
| Free Cash Flow | -14.81M |
| FCF Per Share | -0.1 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TENX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for TENX is $16, which is 175.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $16 |
| Price Target Difference | 175.9% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Jan 3, 2024. It was a backward split with a ratio of 1:80.
| Last Split Date | Jan 3, 2024 |
| Split Type | backward |
| Split Ratio | 1:80 |
Scores
| Altman Z-Score | -1.39 |
| Piotroski F-Score | 2 |